Chronic pulmonary disease and antipyrine disposition.
作者信息
Agnihotri S N, Clark R A, Cooper S, Iyun A O, Tucker G T
出版信息
Br J Clin Pharmacol. 1978 Mar;5(3):275-7. doi: 10.1111/j.1365-2125.1978.tb01641.x.
Abstract
摘要
相似文献
1
Chronic pulmonary disease and antipyrine disposition.
Br J Clin Pharmacol. 1978 Mar;5(3):275-7. doi: 10.1111/j.1365-2125.1978.tb01641.x.
2
Antipyrine metabolism and bronchogenic carcinoma.安替比林代谢与支气管癌
J Med. 1977;8(1):57-70.
4
Metabolic disposition of antipyrine in patients with lung cancer.
Cancer Res. 1977 Nov;37(11):3881-6.
5
The effect of arterial oxygen tension on antipyrine half-time in plasma.动脉血氧张力对血浆中安替比林半衰期的影响。
Clin Pharmacol Ther. 1976 Apr;19(4):498-71.
6
[The oxygen study. Prolonged oxygen therapy at home is of great value for patients with chronic lung failure].[氧疗研究。家庭长期氧疗对慢性肺功能衰竭患者具有重要价值]
Lakartidningen. 1989 Jun 28;86(26-27):2452-5.
7
Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.单位体积肝脏的安替比林清除率：慢性肝病肝功能评估
Gut. 1979 Jul;20(7):596-601. doi: 10.1136/gut.20.7.596.
8
9
Oxygen therapy in chronic obstructive pulmonary disease.
Indian J Chest Dis. 1969 Oct;11(4):186-95.
10
Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine.苏丹肝脾型血吸虫病中的药物代谢：一项关于安替比林的研究。
Gut. 1978 Sep;19(9):808-11. doi: 10.1136/gut.19.9.808.
引用本文的文献
1
Hypoxia, arterial pH and theophylline disposition.缺氧、动脉血pH值与茶碱的处置
Clin Pharmacokinet. 1993 Oct;25(4):283-99. doi: 10.2165/00003088-199325040-00004.
2
Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.囊性纤维化中抗生素及其他药物的临床药理学
Drugs. 1988 May;35(5):542-78. doi: 10.2165/00003495-198835050-00004.
3
The effect of respiratory disorders on clinical pharmacokinetic variables.呼吸系统疾病对临床药代动力学变量的影响。
Clin Pharmacokinet. 1990 Dec;19(6):462-90. doi: 10.2165/00003088-199019060-00004.
4
Pulmonary disease and drug kinetics.肺部疾病与药物动力学
Clin Pharmacokinet. 1978 Jul-Aug;3(4):257-66. doi: 10.2165/00003088-197803040-00001.
本文引用的文献
1
Half-life of tolbutamide in patients with chronic respiratory failure.
Eur J Clin Pharmacol. 1971 Dec;4(1):29-31. doi: 10.1007/BF00568895.
2
Increased clearance of ethanol from the blood of asthmatic patients.哮喘患者血液中乙醇清除率增加。
Ann Allergy. 1972 May;30(5):254-7.
3
Determinants of serum antipyrine half-lives in patients with liver disease.肝病患者血清安替比林半衰期的决定因素。
Gut. 1973 Jul;14(7):569-73. doi: 10.1136/gut.14.7.569.
4
Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.口服和静脉注射后安替比林、甲苯磺丁脲和华法林的血浆水平比较。
Clin Pharmacol Ther. 1974 Dec;16(6):1059-65. doi: 10.1002/cpt19741661059.
5
Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.苯巴比妥治疗后猴子体内安替比林和d-普萘洛尔清除率增加。酶诱导和肝血流量增加的相对作用。
J Clin Invest. 1974 Apr;53(4):1101-7. doi: 10.1172/JCI107647.
6
Rapid gas-liquid chromatographic estimation of antipyrine in plasma.血浆中安替比林的快速气-液色谱法测定
J Pharm Pharmacol. 1973 Mar;25(3):205-7. doi: 10.1111/j.2042-7158.1973.tb10625.x.
7
The effect of arterial oxygen tension on antipyrine half-time in plasma.动脉血氧张力对血浆中安替比林半衰期的影响。
Clin Pharmacol Ther. 1976 Apr;19(4):498-71.
8
Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.人体中安替比林的代谢：年龄、酒精、咖啡因和吸烟的影响。
Clin Pharmacol Ther. 1975 Oct;18(4):425-32. doi: 10.1002/cpt1975184425.
9
The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.苯巴比妥给药前后人体肝脏体积、安替比林清除率和吲哚菁绿清除率之间的关系。
Br J Clin Pharmacol. 1976 Oct;3(5):907-13. doi: 10.1111/j.1365-2125.1976.tb00646.x.
10
Role of blood flow in carbon monoxide- and hypoxic hypoxia-induced alterations in hexobarbital metabolism in rats.血流在一氧化碳和低氧性缺氧诱导的大鼠己巴比妥代谢改变中的作用
Drug Metab Dispos. 1976 Sep-Oct;4(5):460-7.
Zotero 插件